Correction to: Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study, by Cullen KR, Amatya P, Roback MG, Albott CS, Westlund Schreiner M, Ren Y, Eberly LE, Carstedt P, Samikoglu A, Gunlicks-Stoessel M, Reigstad K, Horek N, Tye S, Lim KO, Klimes-Dougan B. J Child Adolesc Psychopharmacol 2018;28(7):437–444. DOI: 10.1089/cap.2018.0030
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.